RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Staidson Beijing BioPharmaceuticals Co - Stock

Staidson Beijing BioPharmaceuticals Co ROA 2024

Staidson Beijing BioPharmaceuticals Co ROA

-0.3

Staidson Beijing BioPharmaceuticals Co Dividend yield

11.13 %

Ticker

300204.SZ

ISIN

CNE100001237

In 2024, Staidson Beijing BioPharmaceuticals Co's return on assets (ROA) was -0.3, a 153.71% increase from the -0.12 ROA in the previous year.

Staidson Beijing BioPharmaceuticals Co Aktienanalyse

What does Staidson Beijing BioPharmaceuticals Co do?

Staidson Beijing BioPharmaceuticals Co Ltd is a leading biopharmaceutical company based in Beijing, China. The company has a long history and a wide range of products and services that make it an important player in the biotechnology field. Staidson Beijing BioPharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Staidson Beijing BioPharmaceuticals Co's Return on Assets (ROA)

Staidson Beijing BioPharmaceuticals Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Staidson Beijing BioPharmaceuticals Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Staidson Beijing BioPharmaceuticals Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Staidson Beijing BioPharmaceuticals Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Staidson Beijing BioPharmaceuticals Co Stock

What is the Return on Assets (ROA) of Staidson Beijing BioPharmaceuticals Co this year?

The Return on Assets (ROA) of Staidson Beijing BioPharmaceuticals Co is -0.3 undefined this year.

What was the ROA of Staidson Beijing BioPharmaceuticals Co compared to the previous year?

The ROA of Staidson Beijing BioPharmaceuticals Co has increased by 153.71% compared to the previous year.

What consequences do high ROA have for investors of Staidson Beijing BioPharmaceuticals Co?

A high ROA is advantageous for investors of Staidson Beijing BioPharmaceuticals Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Staidson Beijing BioPharmaceuticals Co?

A low ROA can be unfavorable for investors of Staidson Beijing BioPharmaceuticals Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Staidson Beijing BioPharmaceuticals Co affect the company?

An increase in ROA of Staidson Beijing BioPharmaceuticals Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Staidson Beijing BioPharmaceuticals Co impact the company?

A reduction in the ROA of Staidson Beijing BioPharmaceuticals Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Staidson Beijing BioPharmaceuticals Co?

Some factors that can influence the ROA of Staidson Beijing BioPharmaceuticals Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Staidson Beijing BioPharmaceuticals Co important for investors?

The ROA of Staidson Beijing BioPharmaceuticals Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Staidson Beijing BioPharmaceuticals Co take to improve ROA?

To improve ROA, Staidson Beijing BioPharmaceuticals Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Staidson Beijing BioPharmaceuticals Co pay?

Over the past 12 months, Staidson Beijing BioPharmaceuticals Co paid a dividend of 0.67 CNY . This corresponds to a dividend yield of about 11.13 %. For the coming 12 months, Staidson Beijing BioPharmaceuticals Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Staidson Beijing BioPharmaceuticals Co?

The current dividend yield of Staidson Beijing BioPharmaceuticals Co is 11.13 %.

When does Staidson Beijing BioPharmaceuticals Co pay dividends?

Staidson Beijing BioPharmaceuticals Co pays a quarterly dividend. This is distributed in the months of June, May, April, June.

How secure is the dividend of Staidson Beijing BioPharmaceuticals Co?

Staidson Beijing BioPharmaceuticals Co paid dividends every year for the past 0 years.

What is the dividend of Staidson Beijing BioPharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Staidson Beijing BioPharmaceuticals Co located?

Staidson Beijing BioPharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Staidson Beijing BioPharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Staidson Beijing BioPharmaceuticals Co from 5/17/2019 amounting to 0.668 CNY, you needed to have the stock in your portfolio before the ex-date on 5/17/2019.

When did Staidson Beijing BioPharmaceuticals Co pay the last dividend?

The last dividend was paid out on 5/17/2019.

What was the dividend of Staidson Beijing BioPharmaceuticals Co in the year 2023?

In the year 2023, Staidson Beijing BioPharmaceuticals Co distributed 0 CNY as dividends.

In which currency does Staidson Beijing BioPharmaceuticals Co pay out the dividend?

The dividends of Staidson Beijing BioPharmaceuticals Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Staidson Beijing BioPharmaceuticals Co

Our stock analysis for Staidson Beijing BioPharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Staidson Beijing BioPharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.